Skip to main content
. 2020 Sep 16;40(9):BSR20201696. doi: 10.1042/BSR20201696

Figure 8. Effects of microRNA (miR)-132 agomiR on fibrosis in cardiac fibroblasts (CFs) treated with angiotensin (Ang) II.

Figure 8

The expression levels of collagen I, collagen III, transforming growth factor-β (TGF-β), and α-smooth muscle actin (α-SMA) were increased in Ang II-treated CFs, and these increases were inhibited by miR-132 agomiR treatment. *P<0.05 versus the PBS+NC agomiR group; #P<0.05 versus the Ang II+NC agomiR group.